The report declares Darktrace’s Enterprise Immune System “a strong example of leveraging artificial intelligence” and “one of the few cases where talk about use of AI in cyber security has turned into action”.
“Darktrace’s core technology now works across all enterprise infrastructure scenarios, spanning on-premises physical and virtual, as well as cloud environments in both the infrastructure-as-a-service and software-as-a-service modes,” said Rik Turner and Mike Sapien at Ovum. “The incorporation of unsupervised, supervised, and deep learning into its product offering puts Darktrace well ahead of the game and makes it a compelling candidate for any enterprise’s cybersecurity tooling plans going forward.
Given that security talent is increasingly scarce while the threat landscape continues to mushroom, only by embracing AI can cyber security hope to lower the security resource demand in the enterprise and improve the odds for the defenders of enterprise infrastructure.”
Mimicking the intelligence of the human immune system, the Enterprise Immune System works by learning the normal ‘pattern of life’ within an organization, and using that understanding to detect and fight back against in-progress attacks in real time. Capable of identifying and remediating subtle and stealthy threats, as well as fast or automated attacks, the technology is widely recognized today as a step change in the way organizations address the entire spectrum of cyber challenges.
“Darktrace has overcome a massive engineering challenge to deliver the world’s first AI platform proven to not only detect but also autonomously respond to in-progress attacks in real time,” said Nicole Eagan, CEO at Darktrace. “We are delighted that Ovum has recognized the fundamental power of our technology and Darktrace’s market leadership.”
________________________________________________